Gabrielle R Neises

Title: Gabrielle R Neises: Innovator in Glycolipid Synthesis and Tay-Sachs Treatment

Introduction

Gabrielle R Neises is a prominent inventor based in Chesterfield, MO (US). She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds for medical applications. With a total of 10 patents, her work has had a substantial impact on the treatment of genetic disorders.

Latest Patents

Among her latest patents, Neises has developed deoxygalactonojirimycin derivatives. These novel N-alkyl derivatives contain alkyl groups with 3-6 carbon atoms and are useful for selectively inhibiting glycolipid synthesis. Additionally, she has disclosed a method for treating Tay-Sachs disease, which involves subjecting cells to a glycolipid inhibitory effective amount of an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol, where the alkyl contains 2-8 carbon atoms.

Career Highlights

Throughout her career, Neises has worked with notable companies such as Monsanto Company and G.D. Searle & Company. Her experience in these organizations has allowed her to refine her expertise in biochemistry and patent development.

Collaborations

Some of her notable coworkers include Frances M Platt and Raymond A Dwek. Their collaborative efforts have contributed to advancements in the field and have furthered the impact of Neises's inventions.

Conclusion

Gabrielle R Neises is a trailblazer in the field of biochemistry, with a focus on innovative treatments for genetic disorders. Her contributions through her patents and collaborations continue to influence the medical community.